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Background: To analyze the presence of burning mouth syndrome (BMS) in a group of patients diagnosed with 
oral lichenoid disease (OLD).
Material and Methods: A retrospective study of 217 patients diagnosed with OLD; 158 (72,8%) women and 59 
(27,2%) men, with an average age upon diagnosis of 56,4 years (SD 11,88). We carried out a detailed and com-
plete characterization of symptoms, with special emphasis on BMS diagnostic data specified by the International 
Headache Society.
Results: Four patients (1.8%) presented with long-term clinical symptoms of burning mouth, indicative of BMS 
and they fulfilled the IHS 2018 criteria, except for criterion D, i.e.“Oral mucosa is of normal appearance”. The 
observed lichenoid mucosal lesions were not considered to be able to account for the reported intraoral pain in any 
of our patients. Thus neither diagnosis was considered to be exclusive.
Conclusions: Patients diagnosed with OLD, and who simultaneously present clinical characteristics of BMS 
should be studied in detail, in order to evaluate the possibility of both diagnoses concurring.
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the affectation and on the functional stimulation of the 
lesioned mucosa, as well as on the ingesting of acidic, 
hot or spicy foods (14).
In the light of the clinical characteristics of these two 
disorders and their possible simultaneous appearance, 
we decided to analyze the presence of BMS in a group 
of patients diagnosed with OLD, identifying key char-
acteristics of these patients.
Material and Methods
Retrospective study of 217 patients clinicopathological-
ly diagnosed with OLD at the Oral Medicine and Oral 
and Maxillofacial Pathology Units which pertain to the 
Service of Clinical Odontology of the University of the 
Basque Country (UPV/EHU), between the years 1999 
and 2014. The sample is made up of 158 (72.8%) women 
and 59 (27.2%) men, with an average age of 56.4 years 
(SD: 11.88) at the time of diagnosis, with a minimum of 
21 and a maximum of 90 years.
This study was approved by the Ethics and Research 
on Human Beings Committee of the University of the 
Basque Country (UPV/EHU; CEISH185/2012). In all 
cases, we carried out a clinicopathological characteriza-
tion of OLD based on established criteria (11,12,15). We 
also carried out a precise evaluation of the oral symp-
toms, paying particular attention to those which could be 
related to BMS. Following the Dental Clinic Service pro-
tocol, patients with symptoms indicative of BMS were 
referred to the Orofacial Pain and Temporomandibular 
Disorders Unit and were studied using a specific proto-
col for diagnosis and characterization of the syndrome. 
In all patients, we ruled out the existence of other local 
and systemic pathologies by carrying out a complete 
oral and maxillofacial exploration, as well as salivary 
and mycological study and blood tests. A descriptive sta-
tistical analysis was performed with the data obtained.
Results
In accordance with clinicopathological criteria previ-
ously established for OLD (12,13,16) 162 (74.7%) pa-
tients were classified as presenting with oral lichen pla-
nus (OLP) and 55 patients (25.4%) with oral lichenoid 
lesion (OLL). Table 1 shows the principal demographic 
data of the study as well as some clinical characteristics. 
In this OLD sample, more than half of patients (50.7%) 
presented with discomfort and/or pain upon being diag-
nosed. The majority of these patients (65.5%) reported 
non-specific discomfort and the remaining 34.5% com-
plained of differing degrees of mucosal pain. Finally, 4 
patients (1.8 %) who had been diagnosed with OLD pre-
sented with daily oral pain which was burning in char-
acter, had lasted for more than 6 months and constituted 
10.5% of pain cases. These patients fulfilled the diagnos-
tic criteria for BMS (1), with the exception of part of cri-
terion D which indicates that “oral mucosa is of normal 
Introduction
Burning mouth syndrome (BMS) is a complex neu-
ropathic disorder characterized by the presence of a 
chronic and constant burning-type pain which is gen-
erally bilateral, localized in the oral mucosa and fre-
quently accompanied by other sensorial alterations, 
principally xerostomia and dysgeusia (1). Although the 
neuropathic nature of the condition was suspected right 
from the earliest descriptions of this syndrome (2) it is 
only in recent years that the neuropathic character of 
the syndrome has been clearly demonstrated, thanks to 
research and the application of a variety of neurophysi-
ological techniques such as the blink reflex, quantitative 
sensory testing or functional magnetic resonance (3-5).
The concept of BMS has undergone numerous modi-
fications over the years. Thus initially, an idiopathic 
primary BMS was identified, as well as a secondary 
BMS associated with local or systemic etiopathogenic 
factors (6,7). This approach made management of these 
patients rather complex since they required different 
complementary tests, some of which were rather com-
plex, as well as a detailed analysis of all the possible fac-
tors which could condition the appearance of the pain-
ful oral symptomatology (6,8). Due to the neuropathic 
nature of the disorder and the lack of clinical evidence 
of the participation of local and/or systemic factors in 
the genesis of BMS, it was decided in the third classifi-
cation of the International Headache Society (IHS) (1) 
that BMS be considered to be a primary process which 
did not require the ruling out of etiopathogenic factors 
for its diagnosis; this approach was, nevertheless, not 
shared by the International Association for the Study 
of Pain (IASP) (9). The IHS considers that the oral mu-
cosa of the patient diagnosed with BMS should have a 
normal appearance, with this criterion remaining un-
changed with respect to the previous classification (1,7).
Thus, the presence of oral lesions in BMS patients re-
mains somewhat controversial. 
Recently, a number of authors have reported patients 
with both oral lichenoid disease (OLD) and BMS (10). 
OLD is an immunologically-based, chronic mucous 
condition which affects mainly peri-menopausal wom-
en. It is characterized by the appearance of white papule 
lesions, occasionally with a reticular, net-like pattern, 
which can be accompanied by other lesions (11,12). 
When patients with OLD present with “white” mu-
cous lesions only, preferentially reticular papules, the 
condition usually evolves without pain, whereas when 
atrophic and above all erosive-ulcerated lesions appear, 
discomfort and pain are usually reported (13). Normally 
discomfort is mild and non-specific and often reported 
as a “sensation of roughness” which is exacerbated upon 
ingesting hot or acidic food (13). The pain associated 
with OLD is located in the superficial mucous and it has 
been reported to exhibit variable intensity depending on 
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appearance”. The principal clinical and symptomatic 
data of these OLD-BMS patients are presented in Table 
2. These cases were called to clinic and an examination 
was performed in January 2020, in which the data of pain 
symptoms and the clinical location of the lesions were 
corroborated, verifying that they had not been modified. 
Furthermore, the clinical course of pain was continued 
and independent of the evolution of the OLD lesions.
Discussion
In 2004, the first diagnostic criteria for BMS were estab-
lished on behalf of the IHS (7). These involved a diag-
nosis of exclusion in which it was necessary to rule out 
possible systemic and local processes which could con-
dition the appearance of intraoral burning, but without 
establishing a time of minimum duration. In addition, 
the oral mucosa should have a normal appearance and 
all recognizable local and/or systemic causes should be 
ruled out. In the recent 2018 classification of the IHS 
(1), a temporal parameter for pain has been established, 
i.e. for more than 2 hours per day and for more than 
3 months, which has helped rule out other short-term 
pathologies. However, this new classification continues 
to insist that the oral mucosa be of normal appearance. 
The IASP (9) continues to indicate that local and sys-
temic causes must be ruled out in order to be able to es-
tablish a diagnosis of BMS, a principle which is shared 
by the majority of research studies carried out to date 
(16-18). Among the reported local causes are the oral 
diseases which can give rise to intraoral pain, such as 
OLD. In this regard, the IHS (1) and the majority of 
clinical studies of BMS insist that the “oral mucosa is of 
normal appearance and clinical examination including 
sensory testing is normal” thereby excluding all those 
patients who present with diseases of the oral mucosa, 
as is the case of patients with OLD.
In recent years, a number of patients diagnosed with 
oral lichen planus have been reported to present with 
reticular white papular lesions in the oral mucosa and 
with symptoms similar to those of BMS (10). These 
patients, similar to those reported in the present study, 
would not receive the diagnosis of BMS if we applied 
the current diagnostic criteria proposed by the IHS (1).
Table 1: Clinical data of the study sample.






















OLD: Oral Lichenoid Disease; OLP: Oral Lichen Planus; OLL: Oral 
Lichenoid Lesion.
Case OLD/BMS 1 2 3 4
Age (years) and Gender 59 / F 68 / F 66 / F 65 / F
Type of mucosal lesions White reticular papu-les and atrophic areas
Reticular papules and 
white plaque White reticular papules
White reticular pa-
pules
Location of the mucosal 
lesions Buccal mucosa Dorsum of the tongue
Dorsum and lateral of 
the tongue Lateral of the tongue
Location of pain sympto-
matology
2/3 anterior of the 
tongue
Tip of tongue and 
hard palate, anterior 
zone
2/3 anterior of the ton-
gue, mouth floor, inner 
side of the lips and man-
dibular alveolar ridge
Tip of tongue, hard 
palate, inner side of 
the lips and alveolar 
ridge
Duration of pain (months) 24 6 74 20
Days per week 7 7 7 7
Hours per day 16 16 16 24
Pain since the morning Yes Yes Yes Yes
More pain in the evening Yes No Yes Yes
Factors intensifying pain Acidic food Acidic fruit, hot food and drink Acidic fruits
Spices and acidic 
fruits




of mouth swelling Xerostomia
Hipogeusia, sensa-
tion of oral ulceration
OLD: Oral Lichenoid Disease; BMS: Burning Mouth Syndrome; F: female.
Table 2: Symptomatic characterization of patients with OLD and BMS.
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BMS and OLD share a series of demographic character-
istics, such as the age of appearance of both processes, 
i.e. between the 5th and 7th decades of life, as well as 
their gender distribution, with both pathologies being 
more frequent in women (19-23). In addition, the preva-
lence of these oral disorders is also similar; OLD affects 
1.27% of the population (24), whereas BMS affects be-
tween 1 and 3.7% (22).
Overall, when a wide range of samples of both process-
es are studied, as in the present study, the resulting data 
are indicative of a certain degree of coincidence. Thus, 
almost 2% of patients clinicopathologically diagnosed 
with OLD can also have BMS. Consequently, we be-
lieve that none of the diagnoses should be ruled out in 
these cases, and patients should be treated for both dis-
orders, as has been similarly reported for other concur-
ring processes such as BMS with the Sjögren syndrome 
or with other systemic pathologies (25,26).
In addition, the prevalence of BMS found in our sam-
ple of OLD is within the range reported for the general 
population (22). Nevertheless, we have the impression 
that this comorbidity may in fact be higher, simply due 
to the fact that both processes principally affect post 
menopausic women.
It is important to attempt to distinguish both diseases, 
taking into account the characteristics of the painful 
symptomatology presented by patients with OLD, in-
cluding the quality of the pain, its localization, duration 
and frequency, as well as modifying or conditioning 
factors. We should also take into account the topo-
graphic relation existing between the OLD lesions and 
the symptoms which are present, as well as the types 
of mucosal lesion which these patients exhibit. In our 
study, none of the patients with OLD and BMS exhib-
ited a direct relation between the localization of the 
lichenoid mucosal lesions and the pain which they re-
ported. Moreover, regarding the type of mucosal lesions 
present in these patients, the majority were reticular 
papules or white plaques, rather than atrophic, erosive 
or ulcerated lesions, as would have been expected and 
has been reported in symptomatic cases of OLD (27). 
These data are indicative of the simultaneous presence 
of both disorders in the same patient. In addition, the 
prevalence of BMS found in our sample of OLD is in 
the range described for the general population (22) and 
therefore it was statistically predictable.
Another important differential characteristic of these 
patients with both OLD and BMS is the duration of the 
symptomatology, as well as the presence of other symp-
toms in addition to pain. Concerning symptom dura-
tion, in the four cases reported here, pain was continu-
ous and had lasted for more than 6 months. This is more 
a characteristic of BMS pain rather than a characteristic 
of oral mucosal pain (22). Regarding other symptoms, 
in all cases we recognized the presence of accompa-
nying sensorial alterations, with xerostomia being the 
most frequent, in keeping with the typical clinical char-
acteristics of BMS (22).
To conclude, the results of our study show the existence 
of patients with both OLD and BMS. Consequently, we 
consider that it is not appropriate to exclude in a sys-
tematic way the diagnosis of BMS in those patients who 
present lesions in the oral mucosa. On the basis of these 
results, we think that the redaction of the criterion D of 
the IHS “oral mucosa is of normal appearance and clini-
cal examination including sensory testing is normal” is 
adequate for clinical investigations protocols. However, 
this criterion could be too restrictive for correct BMS 
diagnosis in daily clinical practice. On the other hand, 
the description of the clinical presentation of BMS by 
both the IHS and the IASP (1,9), in which it is indicated 
that there are no lesions that justify burning pain would 
allow the diagnosis of both processes. This modification 
of the clinical evaluation of BMS patients would facili-
tate a more adequate treatment of these cases.
We are aware of the limitations of our study, although 
it is true that it is difficult to design a prospective study 
given the low chance of finding both diseases in the 
same patient.
Finally, we would like to insist on the necessity of al-
ways carrying out a complete exploration of the oral 
mucosa in these patients in order to evaluate the exis-
tence of mucosal lesions, before ruling out a BMS di-
agnosis, as can occur in some patients diagnosed with 
OLD. It should not be forgotten that OLD is a potential-
ly malignant disorder of the oral mucosa and that all of 
the lesions present in these patients should be analyzed, 
treated and controlled in an appropriate way, always 
paying attention to the symptomatology reported by the 
patient.
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